174 related articles for article (PubMed ID: 35718970)
1. Solid Lipid Nanoformulation of Berberine Attenuates Doxorubicin Triggered
Rawal S; Gupta P; Bhatnagar P; Yadav HN; Dinda AK
Comb Chem High Throughput Screen; 2022; 25(10):1695-1706. PubMed ID: 35718970
[TBL] [Abstract][Full Text] [Related]
2. Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway.
Wu YZ; Zhang L; Wu ZX; Shan TT; Xiong C
Oxid Med Cell Longev; 2019; 2019():2150394. PubMed ID: 31885776
[TBL] [Abstract][Full Text] [Related]
3. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
Liu H; Li Y; Zhang X; Shi M; Li D; Wang Y
Can Respir J; 2022; 2022():8509396. PubMed ID: 35465190
[TBL] [Abstract][Full Text] [Related]
5. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhiza glabra (Licorice) root extract attenuates doxorubicin-induced cardiotoxicity via alleviating oxidative stress and stabilising the cardiac health in H9c2 cardiomyocytes.
Upadhyay S; Mantha AK; Dhiman M
J Ethnopharmacol; 2020 Aug; 258():112690. PubMed ID: 32105749
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits doxorubicin-triggered cardiomyocyte apoptosis via attenuating mitochondrial dysfunction and increasing Bcl-2 expression.
Lv X; Yu X; Wang Y; Wang F; Li H; Wang Y; Lu D; Qi R; Wang H
PLoS One; 2012; 7(10):e47351. PubMed ID: 23077597
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD44 and EGFR Dual-Targeted Solid Lipid Nanoparticles for Delivery of Doxorubicin to Triple-Negative Breast Cancer Cell Line: Preparation, Statistical Optimization, and
Darabi F; Saidijam M; Nouri F; Mahjub R; Soleimani M
Biomed Res Int; 2022; 2022():6253978. PubMed ID: 35845934
[TBL] [Abstract][Full Text] [Related]
9. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
10. Bcl-xL is required for the protective effects of low-dose berberine against doxorubicin-induced cardiotoxicity through blocking apoptosis and activating mitophagy-mediated ROS elimination.
Chen B; Zhang JP
Phytomedicine; 2022 Jul; 101():154130. PubMed ID: 35526324
[TBL] [Abstract][Full Text] [Related]
11. Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts.
Coelho AR; Martins TR; Couto R; Deus C; Pereira CV; Simões RF; Rizvanov AA; Silva F; Cunha-Oliveira T; Oliveira PJ; Serafim TL
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2904-2923. PubMed ID: 28760703
[TBL] [Abstract][Full Text] [Related]
12. Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes.
Mao M; Zheng W; Deng B; Wang Y; Zhou D; Shen L; Niku W; Zhang N
PLoS One; 2023; 18(10):e0292124. PubMed ID: 37824478
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment.
Xiong C; Wu YZ; Zhang Y; Wu ZX; Chen XY; Jiang P; Guo HC; Xie KR; Wang KX; Su SW
Oncol Lett; 2018 Apr; 15(4):5721-5729. PubMed ID: 29552206
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro.
Wang WC; Uen YH; Chang ML; Cheah KP; Li JS; Yu WY; Lee KC; Choy CS; Hu CM
BMC Complement Altern Med; 2012 Aug; 12():138. PubMed ID: 22920231
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro.
Liu Z; Song XD; Xin Y; Wang XJ; Yu H; Bai YY; Liu JH; Zhang CN; Hui RT
Chin Med J (Engl); 2009 Nov; 122(21):2652-6. PubMed ID: 19951587
[TBL] [Abstract][Full Text] [Related]
16. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M
Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064
[TBL] [Abstract][Full Text] [Related]
17. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
Nakhlband A; Eskandani M; Saeedi N; Ghafari S; Omidi Y; Barar J; Garjani A
Colloids Surf B Biointerfaces; 2018 Apr; 164():299-307. PubMed ID: 29413609
[TBL] [Abstract][Full Text] [Related]
18. Lotusine, an alkaloid from Nelumbo nucifera (Gaertn.), attenuates doxorubicin-induced toxicity in embryonically derived H9c2 cells.
Harishkumar R; Selvaraj CI
In Vitro Cell Dev Biol Anim; 2020 May; 56(5):367-377. PubMed ID: 32468412
[TBL] [Abstract][Full Text] [Related]
19. MSCs enhances the protective effects of valsartan on attenuating the doxorubicin-induced myocardial injury via AngII/NOX/ROS/MAPK signaling pathway.
Cheng D; Tu W; Chen L; Wang H; Wang Q; Liu H; Zhu N; Fang W; Yu Q
Aging (Albany NY); 2021 Sep; 13(18):22556-22570. PubMed ID: 34587120
[TBL] [Abstract][Full Text] [Related]
20. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Zheng G; Zheng M; Yang B; Fu H; Li Y
Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
